Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2017 / Articles / Jun / When Experiments Go Wrong
Manufacture Business Practice Small Molecules Trends & Forecasts Small Molecules

When Experiments Go Wrong

Laboratory safety is a priority for all. We need to get better at sharing data on hazardous chemical reactions.

By Carmen Nitsche 06/21/2017 1 min read

Share

In February 2017, a PhD student at the University of Bristol in the UK was conducting a routine experiment. An unanticipated reaction created triacetone triperoxide – a highly explosive substance – and the emergency services were called to carry out a controlled explosion. Fortunately, no one was hurt, but the incident highlights how easy it is to unintentionally create a hazardous chemical or unwanted reaction, particularly in a research institution. A chemical reaction doesn’t have to create an explosion to be hazardous. Depending on the scale of the reaction, reagents can violently interact to shatter glassware, spew forth toxic gases or burst into flame. There are numerous books, databases and other resources available that outline reagent safety information, but what would be more beneficial is a searchable, freely available database on unintended reaction incidents and near-misses. Such practical information does exist of course – but it’s often locked in internal silos, where it is difficult to find and share even within a company, much less across organizations (nobody likes to admit when an experiment has gone horribly wrong...).

As the life sciences industry relies on experimentation to develop new products, there is no way to eliminate risks entirely. However, the same negative incidents should never happen twice. Researchers need access to previously reported dangers. To this end, The Pistoia Alliance has recently developed the Chemical Safety Library Service. The service allows the research community to submit, store and share hazardous chemical 
reaction information.

The library has been seeded by members of The Pistoia Alliance, with a number of incidents from their archives. Members can add and share their chemistry reaction-related incidents and learnings – and the content is free to download and integrate for use with internal informatics systems, such as electronic lab notebooks or inventory systems. These systems can also be configured to alert scientists if there is a potential known safety risk before they carry out an experiment. Since the majority of safety information falls in the precompetitive arena, sharing this kind of experience should be straightforward. Moreover, in cases that do involve proprietary components, the Chemical Safety Library offers a function to convey these important safety learnings without revealing company 
intellectual property. The Pistoia Alliance is a global not-for-profit organization that intends to help lower the barriers to innovation in life sciences R&D – and one of our key focuses is collaboration. Our library service could help increase laboratory safety, but we need the life sciences community to embrace this effort. Following the launch of the Chemical Safety Library Service in March 2017, requests for access have been overwhelming. The positive response shows just how much the industry is looking for such a resource. But looking is not enough! Ultimately, the more data the Chemical Safety Library contains, the more useful it becomes to the entire industry. We need companies to move beyond their reticence to share and to add data on hazardous chemical reactions. The process only takes a few minutes. Safety is everyone’s concern and now every researcher can embrace the responsibility and do something constructive about it.

For more information, visit www.pistoiaalliance.org/projects/chemical-safety-library/

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Carmen Nitsche

Carmen Nitsche is a Business Development Consultant at The Pistoia Alliance, USA.

More Articles by Carmen Nitsche

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.